Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

BMC Cancer

Table 1 Clinical-pathological characteristics of ICC patients

Tumor	Primary/Recurrence	HBV-HCV	TNM	Tumor size	K-RAS mutation	Smoking status
CHC-001	primary	neg	p T2b pN0 G2	40 mm	KRAS G12A	Yes
CHC-002	recurrence	HBV pos	r pT2b N0 G3	27 mm	WT	No
CHC-003	primary	neg	p T2 N1 G2	35 mm	WT	No
CHC-005	primary	neg	pT2b pN0 G3	90 mm	WT	Yes
CHC-006	primary	neg	pT2N0 G3	NA	WT	No
CHC-007	primary	neg	pT4 pN0 G3	70 mm	WT	No
CHC-009	primary	neg	pT2b pN0G2-G3	65 mm	WT	No
CHC-010	primary	HCV pos	pT2a pN0 G3	80 mm	WT	No
CHC-011	primary	neg	pT2b pN0 G3	45 mm	WT	Yes
CHC012	recurrence	neg	r pT2b G2	45 mm	WT	No
CHC013	primary	HBV pos	pT2a G3	NA	WT	No
CHC014	primary	neg	pT3 N1 G3	115 mm	WT	No
CHC015	primary	neg	p T2a pN1 G3	100 mm	WT	No
CHC017	recurrence	neg	r pT2a pN0 G2	25 mm	WT	No
CHC018	primary	neg	pT3 N1 G3	75 mm	WT	Yes
CHC019	primary	neg	pT2bN1 G3	15 mm	WT	No
CHC020	primary	neg	pT2b pN0 G2	110 mm	WT	No

ISSN: 1471-2407